The biggest problem with Alzheimer's is that while some treatments have been announced, there is no fundamental and universal treatment to date. The best way to date is to diagnose Alzheimer's as early as possible and delay its exacerbation with drugs early.

We aim to launch an in vitro diagnostic product that can diagnose Alzheimer's dementia in the very early stages or earlier stage of mild recognition.

Using blood-based in vitro diagnostic devices has the advantage of being able to obtain high-accuracy Alzheimer's test results at a low price without side effects compared to conventional cerebrospinal fluid tests and PET tests. Specifically, the test cost will be around 100,000 to 200,000 won, and the test time will provide about 90% accuracy within an hour.